The impact of statins use in clinically localized prostate cancer treated with radical prostatectomy;Influencia del empleo de estatinas en el cáncer de próstata clínicamente localizado tratado con prostatectomía radical

Actas Urologicas Espanolas

Volumn 33, Issue 4, 2009, Pages 351-355

  Mora, Enrique Rijo ^a   Lorente Garin, José A ^b   Galí, Oscar Bielsa ^a   Comalat, Albert Frances ^a   Ciutat, Lluis Fumado ^a   Toro, Octavio Arango ^a  

^a HOSPITAL DEL MAR   (Spain)

^b NONE

Author keywords

Prevention; Prostate cancer; Prostatectomy; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; HUMAN; MALE; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY;

AGED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 68349161230     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(09)74159-2     Document Type: Article

References (10)

1. Schaffner CP. Prostatic cholesterol metabolism regulation and alteration. Prog Clin Biol Res 1981;75A:279-324.
2. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology 1996;137(10):4468-4474.
3. Solomon KR, Freeman MR. Do the cholesterol-lowering properties of statins affect cancer risk?. Trends Endocrinol Metab 2008; 19(4): 113-121.
4. Colli JL, Amling CL. High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States. Urol Oncol 2008; Article in Press.
5. Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Statins and Cancer Risk: A Literature-Based Meta-Analysis and Meta- Regression Analysis of 35 Randomized Controlled Trials. J Clin Oncol 2006;24(30):4808-4817.
6. Bonovas S, Filioussi K, Sitaras NM. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational Studies. Int J Cancer 2008;123(4):899- 904.
7. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol 2008; 168(3): 250-260.
8. Browning DR, Martin RM. Statins and risk of cancer: A systematic review and metaanalysis. Int J Cancer 2007; 120(4):833- 843.
9. Moyad MA, Merrick GS. Statins and cholesterol lowering after a cancer diagnosis: Why not?. Urol Oncol 2005;23(1):49-55.
10. Moyad MA, Merrick GS, Butler WM, Wallner KE, Galbreath RW, Kurko B, et al. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression- free survival after Brachytherapy for clinically localized prostate cancer. Urology 2005;66(6): 1150-1154.